Literature DB >> 24868089

At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer.

Dana M Hardbower1, Richard M Peek2, Keith T Wilson3.   

Abstract

Helicobacter pylori infection is the strongest known risk factor for the development of gastric cancer. Given that ∼50% of the global population is infected with this pathogen, there is great impetus to elucidate underlying causes that mediate progression from infection to cancer. Recent evidence suggests that H. pylori-induced chronic inflammation and oxidative stress create an environment conducive to DNA damage and tissue injury. DNA damage leads to genetic instability and eventually, neoplastic transformation. Pathogen-encoded virulence factors induce a robust but futile immune response and alter host pathways that lower the threshold for carcinogenesis, including DNA damage repair, polyamine synthesis and catabolism, antioxidant responses, and cytokine production. Collectively, such dysregulation creates a protumorigenic microenvironment within the stomach. This review seeks to address each of these aspects of H. pylori infection and to call attention to areas of particular interest within this field of research. This review also seeks to prioritize areas of translational research related to H. pylori-induced gastric cancer based on insights garnered from basic research in this field. See related review by Dalal and Moss, At the Bedside: H. pylori, dysregulated host responses, DNA damage, and gastric cancer.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  DFMO; carcinogenesis; oxidative stress

Mesh:

Year:  2014        PMID: 24868089      PMCID: PMC4101087          DOI: 10.1189/jlb.4BT0214-099R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  105 in total

Review 1.  Microbiota in the stomach: new insights.

Authors:  Wen Ming Wu; Yun Sheng Yang; Li Hua Peng
Journal:  J Dig Dis       Date:  2014-02       Impact factor: 2.325

2.  The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice.

Authors:  K A Eaton; M Mefford; T Thevenot
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

3.  Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells.

Authors:  M R Terebiznik; C L Vazquez; K Torbicki; D Banks; T Wang; W Hong; S R Blanke; M I Colombo; N L Jones
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

4.  Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients.

Authors:  Jason A Zell; Christine E McLaren; Wen-Pin Chen; Patricia A Thompson; Eugene W Gerner; Frank L Meyskens
Journal:  J Natl Cancer Inst       Date:  2010-08-26       Impact factor: 13.506

5.  Helicobacter pylori induces macrophage apoptosis by activation of arginase II.

Authors:  Alain P Gobert; Yulan Cheng; Jian-Ying Wang; Jean-Luc Boucher; Ramaswamy K Iyer; Stephen D Cederbaum; Robert A Casero; Jamie C Newton; Keith T Wilson
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

6.  Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa.

Authors:  G R Davies; N Banatvala; C E Collins; M T Sheaff; Y Abdi; L Clements; D S Rampton
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

7.  DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice.

Authors:  Lisiane B Meira; James M Bugni; Stephanie L Green; Chung-Wei Lee; Bo Pang; Diana Borenshtein; Barry H Rickman; Arlin B Rogers; Catherine A Moroski-Erkul; Jose L McFaline; David B Schauer; Peter C Dedon; James G Fox; Leona D Samson
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

8.  Helicobacter pylori and H2O2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells.

Authors:  Song-Ze Ding; Ann M O'Hara; Tim L Denning; Bernadette Dirden-Kramer; Randy C Mifflin; Victor E Reyes; Kieran A Ryan; Susan N Elliott; Tadahide Izumi; Istvan Boldogh; Sankar Mitra; Peter B Ernst; Sheila E Crowe
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

9.  Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.

Authors:  Rupesh Chaturvedi; Mohammad Asim; M Blanca Piazuelo; Fang Yan; Daniel P Barry; Johanna Carolina Sierra; Alberto G Delgado; Salisha Hill; Robert A Casero; Luis E Bravo; Ricardo L Dominguez; Pelayo Correa; D Brent Polk; M Kay Washington; Kristie L Rose; Kevin L Schey; Douglas R Morgan; Richard M Peek; Keith T Wilson
Journal:  Gastroenterology       Date:  2014-02-13       Impact factor: 22.682

10.  Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells.

Authors:  Lars L Eftang; Ying Esbensen; Tone M Tannæs; Ida R K Bukholm; Geir Bukholm
Journal:  BMC Microbiol       Date:  2012-01-17       Impact factor: 3.605

View more
  32 in total

1.  EGFR regulates macrophage activation and function in bacterial infection.

Authors:  Dana M Hardbower; Kshipra Singh; Mohammad Asim; Thomas G Verriere; Danyvid Olivares-Villagómez; Daniel P Barry; Margaret M Allaman; M Kay Washington; Richard M Peek; M Blanca Piazuelo; Keith T Wilson
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

2.  Genetic Manipulation of Helicobacter pylori Virulence Function by Host Carcinogenic Phenotypes.

Authors:  Giovanni Suarez; Judith Romero-Gallo; Johanna C Sierra; M Blanca Piazuelo; Uma S Krishna; Martin A Gomez; Keith T Wilson; Richard M Peek
Journal:  Cancer Res       Date:  2017-02-16       Impact factor: 12.701

Review 3.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

4.  Oxidative and nitrosative stress defences of Helicobacter and Campylobacter species that counteract mammalian immunity.

Authors:  Annika Flint; Alain Stintzi; Lígia M Saraiva
Journal:  FEMS Microbiol Rev       Date:  2016-11-01       Impact factor: 16.408

5.  Ornithine decarboxylase (ODC1) gene variant (rs2302615) is associated with gastric cancer independently of Helicobacter pylori CagA serostatus.

Authors:  Anna K Miller; Gloria Tavera; Scott M Williams; Douglas R Morgan; Ricardo L Dominguez; M Constanza Camargo; Tim Waterboer; Keith T Wilson
Journal:  Oncogene       Date:  2021-08-10       Impact factor: 9.867

Review 6.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Manuel Amieva; Richard M Peek
Journal:  Gastroenterology       Date:  2015-09-16       Impact factor: 22.682

Review 7.  Polyamine metabolism and cancer: treatments, challenges and opportunities.

Authors:  Robert A Casero; Tracy Murray Stewart; Anthony E Pegg
Journal:  Nat Rev Cancer       Date:  2018-11       Impact factor: 60.716

8.  Arginase 2 deletion leads to enhanced M1 macrophage activation and upregulated polyamine metabolism in response to Helicobacter pylori infection.

Authors:  Dana M Hardbower; Mohammad Asim; Tracy Murray-Stewart; Robert A Casero; Thomas Verriere; Nuruddeen D Lewis; Rupesh Chaturvedi; M Blanca Piazuelo; Keith T Wilson
Journal:  Amino Acids       Date:  2016-04-13       Impact factor: 3.520

Review 9.  Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.

Authors:  Dustin J Flanagan; Elizabeth Vincan; Toby J Phesse
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739

Review 10.  The stomach in health and disease.

Authors:  R H Hunt; M Camilleri; S E Crowe; E M El-Omar; J G Fox; E J Kuipers; P Malfertheiner; K E L McColl; D M Pritchard; M Rugge; A Sonnenberg; K Sugano; J Tack
Journal:  Gut       Date:  2015-09-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.